- Home
- WTTR vs SYRE Comparison
WTTR vs SYRE Comparison
Compare WTTR & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTTR
- SYRE
- Stock Information
- Founded
- WTTR 2016
- SYRE 2013
- Country
- WTTR United States
- SYRE United States
- Employees
- WTTR N/A
- SYRE N/A
- Industry
- WTTR Oilfield Services/Equipment
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- WTTR Energy
- SYRE Health Care
- Exchange
- WTTR Nasdaq
- SYRE Nasdaq
- Market Cap
- WTTR 922.1M
- SYRE 841.4M
- IPO Year
- WTTR 2017
- SYRE 2016
- Fundamental
- Price
- WTTR $9.04
- SYRE $15.50
- Analyst Decision
- WTTR Strong Buy
- SYRE Buy
- Analyst Count
- WTTR 3
- SYRE 6
- Target Price
- WTTR $14.83
- SYRE $55.00
- AVG Volume (30 Days)
- WTTR 821.6K
- SYRE 626.6K
- Earning Date
- WTTR 07-29-2025
- SYRE 08-06-2025
- Dividend Yield
- WTTR 3.09%
- SYRE N/A
- EPS Growth
- WTTR N/A
- SYRE N/A
- EPS
- WTTR 0.34
- SYRE N/A
- Revenue
- WTTR $1,459,911,000.00
- SYRE N/A
- Revenue This Year
- WTTR $2.68
- SYRE N/A
- Revenue Next Year
- WTTR $5.03
- SYRE N/A
- P/E Ratio
- WTTR $26.24
- SYRE N/A
- Revenue Growth
- WTTR N/A
- SYRE N/A
- 52 Week Low
- WTTR $7.20
- SYRE $10.91
- 52 Week High
- WTTR $15.14
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- WTTR 55.19
- SYRE 48.30
- Support Level
- WTTR $8.52
- SYRE $14.00
- Resistance Level
- WTTR $8.88
- SYRE $17.29
- Average True Range (ATR)
- WTTR 0.30
- SYRE 1.33
- MACD
- WTTR -0.02
- SYRE -0.15
- Stochastic Oscillator
- WTTR 51.49
- SYRE 38.29
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.